ARCHIVES

FDA Approves Imaging Agent For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

BMI May Be Prognostic Tool For Types Of Breast Cancer

March 28, 2008

Budget Would Support 1,211 More Grants

February 7, 2003

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

Avoiding Mediastinal Radiation Can Improve Patient Outcomes

April 26, 2013

Gori To Leave NCI For Job At Franklin Institute

April 18, 1980

DCT Board Approves Contract Recompetitions Worth 44.8 Million In First Year Awards

November 5, 1982